Structure-based and ligand-based drug design for HER 2 receptor.
about
TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silicoIdentification of potent EGFR inhibitors from TCM Database@TaiwanIdentifying HER2 inhibitors from natural products databaseScreening from the world's largest TCM database against H1N1 virus.Structure and stability analysis of cytotoxic complex of camel α-lactalbumin and unsaturated fatty acids produced at high temperature.High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.Investigation of anti-infection mechanism of lactoferricin and splunc-1.Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine.Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine.In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine.Treatment of acute lymphoblastic leukemia from traditional chinese medicineLead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese MedicineLead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicineLead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine.In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening.Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicineIn silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer's disease.An investigation of small GTPases in relation to liver tumorigenesis using traditional Chinese medicine.Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicineFirst principles calculations of thermodynamics and kinetic parameters and molecular dynamics simulations of acetylcholinesterase reactivators: can mouse data provide new insights into humans?Retrieving novel C5aR antagonists using a hybrid ligand-based virtual screening protocol based on SVM classification and pharmacophore models.A conformationally constrained peptidomimetic binds to the extracellular region of HER2 proteinMultiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods.Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.Comparative Proteomics Reveals that Phosphorylation of β Carbonic Anhydrase 1 Might be Important for Adaptation to Drought Stress in Brassica napus.Protein-protein interactions: principles, techniques, and their potential role in new drug development.In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.Biological evaluation and interaction of a newly designed anti-cancer Pd(II) complex and human serum albumin.Molecular modeling studies of Yersinia pestis dihydrofolate reductase.Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.Search for novel remedies to augment radiation resistance of inhabitants of Fukushima and Chernobyl disasters: identifying DNA repair protein XRCC4 inhibitors.Molecular modeling of Mycobacterium tuberculosis dUTpase: docking and catalytic mechanism studies.A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once?In silico pharmacology suggests ginger extracts may reduce stroke risks.Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis.Traditional Chinese medicine as dual guardians against hypertension and cancer?Investigation into potent inflammation inhibitors from traditional Chinese medicine.
P2860
Q28476702-B7DD2620-890F-4B7C-A5C8-039698DD0924Q28477481-341B14A9-5590-4E40-870A-66F9992E54C7Q28478359-85943F9F-4BC9-4A68-A874-E28D54EBB288Q30399346-39E64793-4F4F-497A-B8F3-2D5F4CBE95F8Q30401575-015F17F1-EB02-43D8-AE48-3637973AC880Q30408391-705AED5B-E907-4C3D-8253-BBF7270F2D6EQ33614360-480DB62F-5424-488B-8AA7-65140A82D80BQ33614602-E34F0E2F-12CB-40AF-BE93-0810D4678775Q33614632-6680A930-35F7-459F-B67A-2F2377BB7E0CQ33615005-475CED3C-9FD6-4A91-AB28-A5CC4EFFC775Q33668052-960035F1-AA27-402C-AE07-2CC04FC360C6Q33746550-C3B21946-A80B-4BA5-B6FC-2AD2B0967BB5Q33766033-C066C917-DD9F-400A-995E-5C164CC0EA4AQ33791008-0C88535F-4EC8-47B0-B191-BBCF8C61AED6Q33810342-E6A38314-B909-4FFB-8ED5-E8A2427845DBQ33811917-48734582-5AC5-4E0D-9AEA-532B2A4DE0E1Q33862420-469C5BCC-B7D8-4653-A879-827D7FD4AF86Q33876257-772BE817-F3F1-46CC-83A6-63AE56575F6AQ33876492-ABCD5B98-8360-4FDE-989F-1547B3CE37D4Q33903600-80CBAA74-FDD4-45B3-9990-A7964FC7E828Q34316593-54BEFF8A-D261-425A-85AF-B5E8C573A276Q34351611-D7674B3E-734C-400F-AA59-DF71232596B7Q34422576-FC441D8C-4505-4BE9-8B97-CAD10E0F4A50Q35872435-A050D3B9-9519-4934-8C42-F6673C9D25D0Q36610755-50E9883F-C392-4F72-A6E4-DCC2A456CB25Q37501304-5BB5D864-BA74-4A54-BE64-618B2183B449Q37862224-A61BD989-7B15-4B48-9C6E-868E4F5618B7Q38960185-CCF55B4F-ACBD-4434-8ED3-93CA96C452ABQ39482778-32DC3EDA-7721-42FF-A048-09BD15473483Q41426709-576FD413-6E5A-441F-A31C-94A43920A12AQ41932456-D0B7EC27-5259-4AE2-BD23-BAC39A16F964Q41980724-8B839F9B-7086-492C-B5E5-827A26A87B4DQ43414532-E9166117-F0B0-4BA0-AA2D-14F29F2440F4Q44999449-E0A9F104-FAA6-4DCF-82DD-CB948D78AB31Q45330213-50605C4B-55BD-46C7-BC3A-11FB88747042Q45961690-6249F444-EC7D-4B23-9909-96A077ADEE56Q45961735-1E3A9062-97DB-4BF9-A57C-EC03DB9F1883Q46159949-BC95B0B1-907B-4E21-BE91-DC7EB46E4D97Q47197241-8239312A-B9DD-4457-A4FB-48D61B436596Q47278490-C1B9EA59-4DFD-4218-B37B-DD3DE81E3A19
P2860
Structure-based and ligand-based drug design for HER 2 receptor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Structure-based and ligand-based drug design for HER 2 receptor.
@en
Structure-based and ligand-based drug design for HER 2 receptor.
@nl
type
label
Structure-based and ligand-based drug design for HER 2 receptor.
@en
Structure-based and ligand-based drug design for HER 2 receptor.
@nl
prefLabel
Structure-based and ligand-based drug design for HER 2 receptor.
@en
Structure-based and ligand-based drug design for HER 2 receptor.
@nl
P2093
P2860
P1476
Structure-based and ligand-based drug design for HER 2 receptor.
@en
P2093
Calvin Yu-Chian Chen
Chien-Yu Chen
Chih-Ho Hsu
Fuu-Jen Tsai
Hsin-Yi Chen
Hung-Jin Huang
Kuei-Jen Lee
P2860
P356
10.1080/07391102.2010.10507341
P577
2010-08-01T00:00:00Z